The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Mar. 19, 2024
Filed:
Jul. 13, 2021
Applicant:
Good T Cells, Inc., Seoul, KR;
Inventor:
Sang-kyou Lee, Seoul, KR;
Assignee:
Good T Cells, Inc., Seoul, KR;
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); A61K 35/17 (2015.01); A61K 38/00 (2006.01); C07K 14/47 (2006.01); C12N 15/113 (2010.01); C12Q 1/6876 (2018.01); G01N 33/50 (2006.01); G01N 33/68 (2006.01); G01N 33/94 (2006.01);
U.S. Cl.
CPC ...
C07K 16/18 (2013.01); A61K 35/17 (2013.01); C07K 14/47 (2013.01); C12N 15/113 (2013.01); C12N 15/1138 (2013.01); C12Q 1/6876 (2013.01); G01N 33/5023 (2013.01); G01N 33/505 (2013.01); G01N 33/6854 (2013.01); G01N 33/6872 (2013.01); G01N 33/9493 (2013.01); A61K 38/00 (2013.01); C12N 2310/11 (2013.01); C12N 2310/14 (2013.01); C12N 2310/17 (2013.01); C12Q 2600/136 (2013.01); C12Q 2600/158 (2013.01);
Abstract
The present invention relates to a novel use of regulatory T cell-specific surface protein Lrig-1, and more specifically to an immunosuppressive agent comprising siRNA which inhibits the expression of surface protein Lrig-1. In addition, the invention relates to a method for screening an immunosuppressive agent which inhibits proteins of Lrig-1 or genes encoding the proteins. As a result, an immunosuppressive agent with low side effects and high specificity can be developed.